A case of nocardiosis in a patient with ulcerative colitis on chronic corticosteroids, infliximab, and upadacitinib

被引:1
|
作者
Moy, Benjamin M. M. [1 ,3 ]
Shenoy, Abhishek [2 ]
Aldrich, Leslie B. B. [2 ]
机构
[1] Univ Michigan, Med Sch, Ann Arbor, MI USA
[2] Michigan Med, Dept Internal Med, Div Gastroenterol & Hepatol, Ann Arbor, MI USA
[3] Univ Michigan Hosp, Taubman Ctr 3912, Michigan Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA
来源
CLINICAL CASE REPORTS | 2023年 / 11卷 / 05期
关键词
Crohns; IBD; immunosuppression; JAK inhibitors; Nocardia;
D O I
10.1002/ccr3.7362
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Key Clinical MessageImmunosuppression, malnutrition, and underlying infection can unmask obscure infections which can be challenging to identify. Early diagnosis and treatment of infections in immunosuppressed patients are essential due to high morbidity and mortality. The immunosuppressive effects of treatment for ulcerative colitis (UC), including chronic corticosteroids, anti-TNF agents, and JAK inhibitors, can impact the spread of latent or obscure infections. Clinicians should have a low threshold for pursuing aggressive diagnostic and therapeutic intervention in patients who show signs of clinical deterioration while on immunosuppressing medications. Our unique case highlights an immunosuppressed patient with UC who developed Nocardiosis after initiation of upadacitinib while hospitalized for concurrent UC flare and Clostridium difficile infection.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Upadacitinib for refractory ulcerative colitis with primary nonresponse to infliximab and vedolizumab: A case report
    Xu, Xuan
    Jiang, Jing-Wen
    Lu, Bing-Yun
    Li, Xia-Xi
    WORLD JOURNAL OF CLINICAL CASES, 2024, 12 (09)
  • [2] A Case of Infectious Mononucleosis in a Patient with Ulcerative Colitis on Infliximab
    Bien, Angela
    Gaidos, Jill
    Kuemmerle, John
    Banks, Kasiah
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S505 - S505
  • [3] Upadacitinib for ulcerative colitis
    Ananthakrishnan, Ashwin N.
    LANCET, 2022, 399 (10341): : 2077 - 2078
  • [4] Upadacitinib for ulcerative colitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (08): : 709 - 709
  • [5] Infliximab for hospitalized ulcerative colitis patients failing intravenous corticosteroids
    Regueiro, Miguel
    Curtis, Jennifer
    Plevy, Scott
    GASTROENTEROLOGY, 2006, 130 (04) : A655 - A655
  • [6] A Case of Rothia dentocariosa Bacteremia in a Patient Receiving Infliximab for Ulcerative Colitis
    Yeung, Darwin F.
    Parsa, Ashkan
    Wong, John C.
    Chatur, Nazira
    Salh, Baljinder
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (02): : 297 - 298
  • [7] Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab
    Fok, Kum C.
    Ng, Watson W. S.
    Henderson, Christopher J. A.
    Connor, Susan J.
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (06): : 708 - 712
  • [8] Upadacitinib maintains hidradenitis suppurativa remission in patient with ulcerative colitis
    Rubtsov, Denis
    Malloy, Reuben
    Cohen, Rebecca
    Ducommun, Ruth
    Chapagain, Ayesha
    Khaing, Myat
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 219 - 220
  • [9] Leukocytapheresis in a Girl with Severe Ulcerative Colitis Refractory to Corticosteroids, Infliximab, and Cyclosporine A
    Dittrich, Katalin
    Richter, Markns
    Rascher, Wolfgang
    Koehler, Henrik
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (10) : 1466 - 1467